ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,638.94
2.13%
US Tech 100
19,167.20
2.31%
다우존스 지수
41,488.19
1.65%
Bitcoin
84,425.89
0.09%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC
  6. Hepion Pharmaceuticals Inc (PK) (CTRVP)

  7. Hepion Pharmaceuticals Inc (PK) (CTRVP) 뉴스

CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:CTRVP
일자시간출처헤드라인심볼기업
2025/03/0507:28Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2025/02/0723:53Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2025/02/0723:50Edgar (US Regulatory)Form ARS/A - Annual Report to Security Holders: [Amend]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2025/02/0723:39Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2025/01/2806:31Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2025/01/2806:15Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2025/01/2320:03Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2025/01/2214:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2025/01/2211:56Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2025/01/1606:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2025/01/1423:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/12/2707:22Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/11/1506:52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/11/1506:07Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/09/0519:36Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/09/0519:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/08/1404:57Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/07/2221:33Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/07/2221:28Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/07/1613:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/07/1606:17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/07/1122:46Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/03/0806:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/03/0706:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/02/2210:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/02/2210:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/02/2106:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2024/02/0806:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2023/12/0722:41Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
2023/11/2820:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
 검색 관련기사 보기:USOTC:CTRVP

최근 히스토리

BITMOT
719567
Ggb Fb40 Sc Eur
BIT
P19KG9
BNP Paribas Issuance
NYSE
PAM
Pampa Energia
ASX
BYHO
Bryah Resources
BIT
EMD5
L&G ESG EMG MKT GV BD 0-...
AMEX
PPH
USOTC
GLNS
Golden Star Resources (QB)
BIT
P1SW04
BNP Paribas Issuance
BIT
UC6FW2
Unicredit Bank
LSE
MTL
Metals Exploration
BIT
P1CSH4
BNP Paribas Issuance
TSX
DXCP
Dynamic Short Term Credi...
BIT
LOIL
Wisdomtree Wti Crude Oil...
BIT
P1JZR3
BNP Paribas Issuance
USOTC
FMFP
First Community Financial (PK)
BIT
P1QRG8
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지